https://www.selleckchem.com/pr....oducts/taurochenodeo
In ACS, the rates of any bleeding for AC and AT were 89 per 1000 person years and 134 per 1000 person years, respectively. In STEMI, rates for AC, AP and AT were 93 per 1000 person years, 138 per 1000 person years and 143 per 100 person years, respectively. In ACS, compared with AC, AT increased the hazard of any bleeding (HR 1.47, 95% CI 1.19 to 1.82) but did not reduce MACCE (HR 1.06, 95% CI 0.89 to 1.27). In STEMI, compared with AC, AP and AT increased the hazard of any bleeding (HR 1.77, 95% CI 1.21 to 2.59 and HR
Like
Comment
Share
